Literature DB >> 16138193

Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.

Yumei Zhan1, Courtney Brown, Elizabeth Maynard, Aleksandra Anshelevich, Weihua Ni, I-Cheng Ho, Peter Oettgen.   

Abstract

Ang II is a central mediator of vascular inflammation and remodeling. The transcription factor Ets-1 is rapidly induced in vascular smooth muscle and endothelial cells of the mouse thoracic aorta in response to systemic Ang II infusion. Arterial wall thickening, perivascular fibrosis, and cardiac hypertrophy are significantly diminished in Ets1-/- mice compared with control mice in response to Ang II. The induction of 2 known targets of Ets-1, cyclin-dependent kinase inhibitor p21CIP and plasminogen activator inhibitor-1 (PAI-1), by Ang II is markedly blunted in the aorta of Ets1-/- mice compared with wild-type controls. Expression of p21CIP in VSMCs leads to cellular hypertrophy, whereas expression of p21CIP in endothelial cells is associated with cell cycle arrest, apoptosis, and endothelial dysfunction. PAI-1 promotes the development of perivascular fibrosis. We have identified monocyte chemoattractant protein-1 (MCP-1) as a novel target for Ets-1. Expression of MCP-1 is similarly reduced in Ets1-/- mice compared with control mice in response to Ang II, which results in significantly diminished recruitment of T cells and macrophages to the vessel wall. In summary, our results support a critical role for Ets-1 as a transcriptional mediator of vascular inflammation and remodeling in response to Ang II.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138193      PMCID: PMC1193876          DOI: 10.1172/JCI24403

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  A pitfall of using a second plasmid to determine transfection efficiency.

Authors:  A Farr; A Roman
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.

Authors:  C S HE; S M Wilhelm; A P Pentland; B L Marmer; G A Grant; A Z Eisen; G I Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 3.  The Ets family of transcription factors.

Authors:  B Wasylyk; S L Hahn; A Giovane
Journal:  Eur J Biochem       Date:  1993-01-15

4.  Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.

Authors:  A J Naftilan; R E Pratt; C S Eldridge; H L Lin; V J Dzau
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

5.  Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress.

Authors:  M E Pueyo; W Gonzalez; A Nicoletti; F Savoie; J F Arnal; J B Michel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

6.  In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy.

Authors:  J Higaki; M Aoki; R Morishita; I Kida; Y Taniyama; N Tomita; K Yamamoto; A Moriguchi; Y Kaneda; T Ogihara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

7.  Angiogenesis inhibition by transdominant mutant Ets-1.

Authors:  T Nakano; M Abe; K Tanaka; R Shineha; S Satomi; Y Sato
Journal:  J Cell Physiol       Date:  2000-08       Impact factor: 6.384

8.  Angiotensin II induces formation of the early growth response gene-1 protein in rat vascular smooth muscle cells.

Authors:  A Sachinidis; P Weisser; Y Ko; K Schulte; K Meyer zu Brickwedde; L Neyses; H Vetter
Journal:  FEBS Lett       Date:  1992-11-23       Impact factor: 4.124

9.  Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway.

Authors:  Etsu Suzuki; Hiroshi Satonaka; Hiroaki Nishimatsu; Shigeyoshi Oba; Ryo Takeda; Masao Omata; Toshiro Fujita; Ryozo Nagai; Yasunobu Hirata
Journal:  Circ Res       Date:  2004-06-03       Impact factor: 17.367

10.  Angiotensin II and structural remodeling of coronary vessels in rats.

Authors:  A Ratajska; S E Campbell; J P Cleutjens; K T Weber
Journal:  J Lab Clin Med       Date:  1994-09
View more
  101 in total

Review 1.  Role of microRNAs in endothelial inflammation and senescence.

Authors:  Bing Qin; Huan Yang; Bo Xiao
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

2.  Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress.

Authors:  Talin Ebrahimian; Melissa Wei Li; Catherine A Lemarié; Stefania M C Simeone; Patrick J Pagano; Matthias Gaestel; Pierre Paradis; Sven Wassmann; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

3.  Epithelium-specific ETS-1: a counter-regulatory factor against vascular dysfunction and inflammation.

Authors:  Chun Cheng Andy Chen; Nicholas R Ferreri
Journal:  Am J Hypertens       Date:  2010-12       Impact factor: 2.689

4.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

5.  Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Authors:  John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

6.  CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.

Authors:  Rudy J Castellani; Summer L Nugent; Alan L Morrison; Xiongwei Zhu; Hyoung-Gon Lee; Peggy L R Harris; Vladan Bajić; Hari S Sharma; Shu G Chen; Peter Oettgen; George Perry; Mark A Smith
Journal:  J Neural Transm (Vienna)       Date:  2010-10-24       Impact factor: 3.575

7.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

8.  High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?

Authors:  L A Calò; R Montisci; R Scognamiglio; P A Davis; E Pagnin; S Schiavo; P Mormino; A Semplicini; P Palatini; A D'Angelo; A C Pessina
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

9.  Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy.

Authors:  Xiangbin Xu; Chang-Hoon Ha; Chelsea Wong; Weiye Wang; Angelika Hausser; Klaus Pfizenmaier; Eric N Olson; Timothy A McKinsey; Zheng-Gen Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-06       Impact factor: 8.311

10.  Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis.

Authors:  Guanghua Hao; Zhenhua Han; Zhe Meng; Jin Wei; Dengfeng Gao; Hong Zhang; Nanping Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.